Peter Kies

CFO of Inovio Pharmaceuticals

As of Nov 10, 2026: Peter Kies (CFO, INO) reported no shares bought or sold themselves in the last 12 months (Form 4). INO's Quality Score is -7. Scores as of 10:56 PM ET, 15 minutes behind.

No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for May 20: stock unit conversion (8,700 INO shares).

Bought$012 months Sold$012 months Last filedMay 20stock unit conversion

From SEC Form 4s · Insiders have 2 business days to file a trade

Every trade Peter Kies reported

None in the last 12 months, as filed.

Every Form 4 Peter Kies filed, as filed, on EDGAR

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See INO's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Peter Kies' companies

Where Peter Kies files, with the stock's Quality Score

Stock	Title, as filed	Trades	Quality Score
INOInovio PharmaceuticalsCFO	CFOtitle as of May 21	0	-7

Alerts for Peter Kies

An email for each Form 4 Peter Kies files, with the stock's Quality Score.

Set an alert

A free account. No card.

Use this page

Kept by Andrew Gomes, Breakaway's founder, from the SEC's Form 4 filings. Updated May 20, 2026.

Their filings on the SEC's site

Free to reuse with a link to this page.

How to cite

Breakaway, Peter Kies: CFO at Inovio Pharmaceuticals (INO), May 20, 2026, getbreakaway.com/insiders/peter-kies

Journalists: email support@getbreakaway.com for the data behind this page.

Others who file at Inovio Pharmaceuticals

Insider trades by person

Peter Kies

Every trade Peter Kies reported

Peter Kies' companies

Use this page

Others who file at Inovio Pharmaceuticals

Every insider trade, with its stock's score.